Items where Author is "Lim, Jonathan Chee Woei"
Up a level |
Group by: Item Type | No Grouping
Number of items: 5.
Sun, Zhong and He, Guozhong and Huang, Ninghao and Thilakavathy, Karuppiah and Lim, Jonathan Chee Woei and Subbiah, Suresh Kumar and Xiong, Cheng Long
(2021)
Glycyrrhizic acid: a natural plant ingredient as a drug candidate to
treat COVID-19.
Frontiers in Pharmacology, 12.
art. no. 70725.
pp. 1-8.
ISSN 1663-9812
Sun, Zhong and Xiong, Cheng Long and Teh, Seoh Wei and Lim, Jonathan Chee Woei and Kumar, Suresh and Thilakavathy, Karuppiah
(2019)
Mechanisms of oral bacterial virulence factors in pancreatic cancer.
Frontiers in Cellular and Infection Microbiology, 9.
art. no. 412.
pp. 1-7.
ISSN 2235-2988
Sulaiman, Ibrahim and Tan, Khaishin and Mohtaruddin, Norhafizah and Lim, Jonathan Chee Woei and Stanslas, Johnson
(2017)
Andrographolide restores healthy airway function in toluene diisocyanate-induced occupational mouse asthma model through upregulation of heam oxygenase-1 and activation of Akt/Nrf-2 dependent pathway.
The FASEB Journal, 31 (supp. 1).
ISSN 0892-6638; ESSN: 1530-6860
Sulaiman, Ibrahim and Lim, Jonathan Chee Woei and Soo, Hon Liong and Stanslas, Johnson
(2016)
Molecularly targeted therapies for asthma: current development, challenges and potential clinical translation.
Pulmonary Pharmacology and Therapeutics, 40.
pp. 52-68.
ISSN 1094-5539; ESSN: 1522-9629
Lim, Jonathan Chee Woei and Jeyaraj, Ethel Jeyaseela and Sagineedu, Sreenivasa Rao and Wong, Wai Shiu Fred and Stanslas, Johnson
(2015)
SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-kB nuclear binding in the A549 non-small cell lung cancer cell line.
Pharmacology, 95 (1-2).
pp. 70-77.
ISSN 0031-7012; ESSN: 1423-0313